Literature DB >> 24253048

The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.

Corine Martineau1, Louise Martin-Falstrault, Louise Brissette, Robert Moreau.   

Abstract

Scavenger receptor class B, type I (SR-BI), the Scarb1 gene product, is a receptor associated with cholesteryl ester uptake from high-density lipoproteins (HDL), which drives cholesterol movement from peripheral tissues toward the liver for excretion, and, consequently, Scarb1 null mice are prone to atherosclerosis. Because studies have linked atherosclerosis incidence with osteoporosis, we characterized the bone metabolism in these mice. Bone morphometry was assessed through microcomputed tomography and histology. Marrow stromal cells (MSCs) were used to characterize influence of endogenous SR-BI in cell functions. Total and HDL-associated cholesterol in null mice were increased by 32-60%, correlating with its role in lipoprotein metabolism. Distal metaphyses from 2- and 4-mo-old null mice showed correspondingly 46 and 37% higher bone volume fraction associated with a higher number of trabeculae. Histomorphometric analyses in 2-mo-old null male mice revealed 1.42-fold greater osteoblast surface, 1.37-fold higher percent mineralizing surface, and 1.69-fold enhanced bone formation rate. In vitro assays for MSCs from null mice revealed 37% higher proliferation rate, 48% more alkaline phosphatase activity, 70% greater mineralization potential and a 2-fold osterix (Sp7) expression, yet a 0.5-fold decrease in caveolin-1 (Cav1) expression. Selective uptake levels of HDL-associated cholesteryl oleate and estradiol were similar between MSC from wild-type and Scarb1 null mice, suggesting that its contribution to this process is not its main role in these cells. However, Scarb1 knockout stunted the HDL-dependent regulation of Cav1 genic expression. Scarb1 null mice are not prone to osteoporosis but show higher bone mass associated with enhanced bone formation.

Entities:  

Keywords:  adrenocorticotropic hormone; caveolin-1; high-density lipoprotein; osteoblasts

Mesh:

Substances:

Year:  2013        PMID: 24253048      PMCID: PMC3920004          DOI: 10.1152/ajpendo.00421.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  62 in total

Review 1.  Osteoporosis in chronic kidney disease.

Authors:  John Cunningham; Stuart M Sprague; Jorge Cannata-Andia; Maria Coco; Martine Cohen-Solal; Lorraine Fitzpatrick; David Goltzmann; Marie-Helene Lafage-Proust; Mary Leonard; Susan Ott; Mariano Rodriguez; Catherine Stehman-Breen; Paula Stern; Jose Weisinger
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

Review 2.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

3.  Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

Authors:  D Calvo; D Gómez-Coronado; Y Suárez; M A Lasunción; M A Vega
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

Review 4.  ACTH is a novel regulator of bone mass.

Authors:  Carlos M Isales; Mone Zaidi; Harry C Blair
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

Review 5.  Role of lipids in osteoporosis.

Authors:  F Parhami; A Garfinkel; L L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

Review 6.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

Review 7.  The pathogenesis, diagnosis, investigation and management of osteoporosis.

Authors:  Sunita K Sandhu; Geeta Hampson
Journal:  J Clin Pathol       Date:  2011-09-06       Impact factor: 3.411

8.  Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting.

Authors:  Menno Hoekstra; Illiana Meurs; Mieke Koenders; Ruud Out; Reeni B Hildebrand; J Kar Kruijt; Miranda Van Eck; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2008-01-19       Impact factor: 5.922

9.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

10.  Caveolin-1 knockout mice have increased bone size and stiffness.

Authors:  Janet Rubin; Zvi Schwartz; Barbara D Boyan; Xian Fan; Natasha Case; Buer Sen; Marcus Drab; Deborah Smith; Maria Aleman; Kevin L Wong; Hai Yao; Hanjoong Jo; Ted S Gross
Journal:  J Bone Miner Res       Date:  2007-09       Impact factor: 6.741

View more
  11 in total

Review 1.  High-density lipoprotein (HDL) metabolism and bone mass.

Authors:  Nicholaos I Papachristou; Harry C Blair; Kyriakos E Kypreos; Dionysios J Papachristou
Journal:  J Endocrinol       Date:  2017-03-17       Impact factor: 4.286

2.  Bone and high-density lipoprotein: The beginning of a beautiful friendship.

Authors:  Dionysios J Papachristou; Harry C Blair
Journal:  World J Orthop       Date:  2016-02-18

3.  Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice.

Authors:  Harry C Blair; Elena Kalyvioti; Nicholaos I Papachristou; Irina L Tourkova; Spryros A Syggelos; Despina Deligianni; Malvina G Orkoula; Christos G Kontoyannis; Eleni A Karavia; Kyriakos E Kypreos; Dionysios J Papachristou
Journal:  Lab Invest       Date:  2016-04-18       Impact factor: 5.662

Review 4.  Fatty acid metabolism by the osteoblast.

Authors:  Priyanka Kushwaha; Michael J Wolfgang; Ryan C Riddle
Journal:  Bone       Date:  2017-08-31       Impact factor: 4.398

5.  Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo.

Authors:  Hee Yeon Won; Se Hwan Mun; Bongjin Shin; Sun-Kyeong Lee
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

6.  Oxidation-specific epitopes restrain bone formation.

Authors:  Elena Ambrogini; Xuchu Que; Shuling Wang; Fumihiro Yamaguchi; Robert S Weinstein; Sotirios Tsimikas; Stavros C Manolagas; Joseph L Witztum; Robert L Jilka
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919

7.  Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass.

Authors:  Michela Palmieri; Teenamol E Joseph; Charles A O'Brien; Horacio Gomez-Acevedo; Stavros C Manolagas; Elena Ambrogini
Journal:  PLoS One       Date:  2022-03-29       Impact factor: 3.240

8.  Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation.

Authors:  Corine Martineau; Olha Kevorkova; Louise Brissette; Robert Moreau
Journal:  Physiol Rep       Date:  2014-10-02

Review 9.  Dual Effects of Lipid Metabolism on Osteoblast Function.

Authors:  Nathalie S Alekos; Megan C Moorer; Ryan C Riddle
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

10.  A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.

Authors:  Michela Palmieri; Ha-Neui Kim; Horacio Gomez-Acevedo; Xuchu Que; Sotirios Tsimikas; Robert L Jilka; Stavros C Manolagas; Joseph L Witztum; Elena Ambrogini
Journal:  J Bone Miner Res       Date:  2020-09-29       Impact factor: 6.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.